Maria Feldman
Career history of Maria Feldman
Former positions of Maria Feldman
Companies | Position | Start | End |
---|---|---|---|
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Chief Operating Officer | 2014-02-28 | - |
Chief Tech/Sci/R&D Officer | 2014-02-28 | - | |
General Counsel | 2016-01-31 | - | |
EVOFEM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - | - |
General Counsel | - | - | |
MEDICINOVA, INC. | General Counsel | 2003-12-31 | - |
Training of Maria Feldman
St. Olaf College | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
General Counsel | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
MEDICINOVA, INC. | Health Technology |
EVOFEM BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Maria Feldman
- Experience